₹120 per test, as against 610,000 tests in November. "As the restrictions for exports of RT-PCR Kits continues, Company has requested Govt.
of India to reopen the exports or allow a new window for taking license," the company said in its stock exchange filing. Recently the company's RT-qPCR kit (version 2.0) got approved for emergency use authorization by USFDFA for testing of saliva specimen samples.
On Friday, the company's scrip on BSE closed 0.5% lower at ₹351.40. Click here to read the Mint ePaperMint is now on Telegram.